Krogsgaard, K <br/><br/>
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.  [electronic resource] 

 -  Journal of hepatology  Dec 1996 
 - 803-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0168-8278 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8278(96)80282-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Biopsy<br/>Chronic Disease<br/>DNA, Viral--analysis<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Synergism<br/>Female<br/>Follow-Up Studies<br/>Glucocorticoids--administration & dosage<br/>Hepatitis B--blood<br/>Hepatitis B Antibodies--analysis<br/>Hepatitis B e Antigens--immunology<br/>Hepatitis B virus--genetics<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Prednisolone--administration & dosage<br/>Transaminases--blood<br/>Treatment Outcome